Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Vaccines for tumour prevention.

Lollini PL, Cavallo F, Nanni P, Forni G.

Nat Rev Cancer. 2006 Mar;6(3):204-16. Review.

PMID:
16498443
2.

Prevention of cancer through immunization: Prospects and challenges for the 21st century.

Frazer IH, Lowy DR, Schiller JT.

Eur J Immunol. 2007 Nov;37 Suppl 1:S148-55. Review.

3.

Vaccines: an innovative approach to treating cancer.

Pazdur MP, Jones JL.

J Infus Nurs. 2007 May-Jun;30(3):173-8. Review.

PMID:
17505219
4.

Vaccination for treatment and prevention of cancer in animal models.

Cavallo F, Offringa R, van der Burg SH, Forni G, Melief CJ.

Adv Immunol. 2006;90:175-213. Review.

PMID:
16730264
5.

Cancer vaccines: preclinical studies and novel strategies.

Palena C, Abrams SI, Schlom J, Hodge JW.

Adv Cancer Res. 2006;95:115-45. Review.

PMID:
16860657
6.

Vaccine therapy for melanoma: current status and future directions.

Terando AM, Faries MB, Morton DL.

Vaccine. 2007 Sep 27;25 Suppl 2:B4-16. Epub 2007 Jul 5. Review.

PMID:
17646038
8.

Promising particle-based vaccines in cancer therapy.

Xiang SD, Scalzo-Inguanti K, Minigo G, Park A, Hardy CL, Plebanski M.

Expert Rev Vaccines. 2008 Sep;7(7):1103-19. doi: 10.1586/14760584.7.7.1103. Review.

PMID:
18767957
9.

Prostate cancer: genes, environment, immunity and the use of immunotherapy.

Karan D, Thrasher JB, Lubaroff D.

Prostate Cancer Prostatic Dis. 2008;11(3):230-6. doi: 10.1038/pcan.2008.3. Epub 2008 Feb 19. Review.

PMID:
18283297
10.

Allogeneic and autologous melanoma vaccines: where have we been and where are we going?

Sondak VK, Sabel MS, Mulé JJ.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2337s-2341s. Review.

11.

Prospects for vaccine therapy for pancreatic cancer.

Gaudernack G.

Best Pract Res Clin Gastroenterol. 2006 Apr;20(2):299-314. Review.

PMID:
16549329
12.

Tissue vaccines for cancer.

Suckow MA, Heinrich J, Rosen ED.

Expert Rev Vaccines. 2007 Dec;6(6):925-37. doi: 10.1586/14760584.6.6.925. Review.

PMID:
18377356
13.

Current progress of DNA vaccine studies in humans.

Lu S, Wang S, Grimes-Serrano JM.

Expert Rev Vaccines. 2008 Mar;7(2):175-91. doi: 10.1586/14760584.7.2.175. Review.

PMID:
18324888
14.

Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations.

Aptsiauri N, Carretero R, Garcia-Lora A, Real LM, Cabrera T, Garrido F.

Cancer Immunol Immunother. 2008 Nov;57(11):1727-33. doi: 10.1007/s00262-008-0532-3. Epub 2008 May 20. Review.

PMID:
18491093
15.

DNA vaccination and gene therapy: optimization and delivery for cancer therapy.

Bodles-Brakhop AM, Draghia-Akli R.

Expert Rev Vaccines. 2008 Sep;7(7):1085-101. doi: 10.1586/14760584.7.7.1085. Review.

PMID:
18767956
16.

Human papillomavirus vaccines for the treatment of cervical cancer.

Sin JI.

Expert Rev Vaccines. 2006 Dec;5(6):783-92. Review.

PMID:
17184217
17.

Present and future of lung cancer vaccines.

Raez LE, Rosenblatt JD, Podack ER.

Expert Opin Emerg Drugs. 2006 Sep;11(3):445-59. Review.

PMID:
16939384
18.

Acquired immune response to oncogenic human papillomavirus associated with prophylactic cervical cancer vaccines.

Einstein MH.

Cancer Immunol Immunother. 2008 Apr;57(4):443-51. Epub 2007 Dec 22. Review.

PMID:
18157723
19.

Cancer prevention: from 1727 to milestones of the past 100 years.

Lippman SM, Hawk ET.

Cancer Res. 2009 Jul 1;69(13):5269-84. doi: 10.1158/0008-5472.CAN-09-1750. Epub 2009 Jun 2. Review.

20.

Anti-cancer vaccines - a one-hit wonder?

Liu JK.

Yale J Biol Med. 2014 Dec 12;87(4):481-9. eCollection 2014 Dec. Review.

Supplemental Content

Support Center